High-functioning Autism Spectrum Disorders
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1)Individual with who have diagnosis of autism spectrum disorder. 2)Verbal intelligence quotient of patients is over 90. 3)Individual with who are above "some need" in Strengths & Difficulties Questionnaires. 4)Age of patients is over 10 to 17 year 5)Caregivers can attend their CBT session with patients. 6)Individual with who have "treatment as usual" does not add an new treatment. 7)Patients can understand CBT. 8)The patients who are diagnosed anxiety disorder and depression can attend this study if they are primaly diagnosed of ASD. 9)Caregivers should not have any psychiatric deseases. 10)Caregivers can attend each CBT session with patients.
Exclusion criteria
Exclusion criteria: 1)Individual with who have an organic disorder 2)Individual with who have suicidal atempt. 3)Individual with who have antisocial conditions. 4)Individual with who have serious psycical disorder. 5)Individual with who have low IQ(under 90 of VIQ) 6)Individual with whoes caregivers cannot attend the sessions.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Adaptive Behavior Composite score for Japanese version of Vineland 2 at 6 weeks after intervention | — |
Secondary
| Measure | Time frame |
|---|---|
| Change from Week 0 (baseline) at 10 weeks for Communication, Daily Living Skills, Social Skills, and Total on the ineland-2 (Parent-Teacher Interview), and scores for each subfactor on the Seehan disability scale (SDISS) and change from Week 0 (baseline) at 6 weeks, change from Week 0 (baseline) at 10 weeks, Student Adaptation to College Questionnaire (SACQ) scores per subfactor, and psychiatric The Internalized Stigma of Illness Scale (ISMI), the total score of the "Stigma Scale" sub-item of the Barriers to Access to Care Evaluation v3 (BACE), and the Patient Health Patient Health Questionnaire-9 (PHQ-9: Depression Scale), Generalized Anxiety Disorder-7 (GAD-7: Anxiety Scale), Meta Cognitive Questionnaire 30 (MCQ30), the total score of Section 2 Knowlege of the Autism Knowledge Quiz for Children and Adolescents (AKQ-C), the total score of Section 3 Ethos of the Autism Knowledge Quiz for Children and Adolescents (AKQ-C), and the total score of the Camouflage Scale (The Camouflage Scale). Camouflaging Autistic Traits Questionnaire (CAT-Q), and scores for each subfactor of the Camouflaging Autistic Traits Questionnaire (CAT-Q). | — |
Countries
Japan
Contacts
Chiba University Research Center for Child Mental Development